Frontiers in Immunology | Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Original Research

Published on 20 Dec 2024

Evaluation of link between COVID-19 adjacent spike in hydroxychloroquine use and increased reports of pemphigus: a disproportionality analysis of the FDA Adverse Event Reporting System

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Justin Baroukhian
Kristina Seiffert-Sinha
Kristopher Attwood
Animesh A. Sinha

Frontiers in Immunology

doi 10.3389/fimmu.2024.1470660

866 views

Review

Published on 20 Dec 2024

Melittin as a therapeutic agent for rheumatoid arthritis: mechanistic insights, advanced delivery systems, and future perspectives

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Ashutosh Pareek
Khushbu Mehlawat
Kritika Tripathi
Aaushi Pareek
Simran Chaudhary
Yashumati Ratan
Vasso Apostolopoulos
Anil Chuturgoon

Frontiers in Immunology

doi 10.3389/fimmu.2024.1510693

1,051 views

Original Research

Published on 19 Dec 2024

Infiltrating macrophages and interferon gamma rather than renal genotype dictate heightened crescentic glomerulonephritis

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Yong Du
Yuyang Fu
Yuyang Gao
Dugyala Poojitha
Vanarsa Kamala
Quanzhen Li
Xinjing Zhou
Chandra Mohan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1484525

751 views

Review

Published on 19 Dec 2024

Unmasking inborn errors of immunity: identifying the red flags of immune dysregulation

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Manuela Cortesi
Laura Dotta
Marco Cattalini
Vassilios Lougaris
Annarosa Soresina
Raffaele Badolato

Frontiers in Immunology

doi 10.3389/fimmu.2024.1497921

1,048 views

Review

Published on 19 Dec 2024

CAR T-cell therapy for systemic lupus erythematosus: current status and future perspectives

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Jincai Zhou
Bixia Lei
Feifei Shi
Xinran Luo
Kai Wu
Yanhong Xu
Yuting Zhang
Rongjiao Liu
Huajing Wang
Joy Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2024.1476859

3,117 views

Original Research

Published on 18 Dec 2024

Serum fatty acid profiles in systemic lupus erythematosus and patient reported outcomes: The Michigan Lupus Epidemiology & Surveillance (MILES) Program

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Kristen N. Gilley
Jenifer I. Fenton
Suzanna M. Zick
Kexin Li
Lu Wang
Wendy Marder
W. Joseph McCune
Raghav Jain
Sidney Herndon-Fenton
Afton L. Hassett

Frontiers in Immunology

doi 10.3389/fimmu.2024.1459297

1,198 views

Original Research

Published on 18 Dec 2024

Efficacy analysis of rituximab in treating patients with primary membranous nephropathy dependent on calcineurin inhibitors

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Zhuo Li
Tingting Zhao
Shasha Zhang
Jing Huang
Honggang Wang
Yujiao Sun
Rong Wang
Bing Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1504646

599 views

Original Research

Published on 18 Dec 2024

Myeloid-specific deletion of autotaxin inhibits rheumatoid arthritis and osteoclastogenesis

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Gwangbeom Heo
Sihyun Jeong
Soyeong Park
Su Jin Kim
Yunna Lee
Seong Ji Woo
Kyunghwan Kim
Byung-Hyun Park
Sang Hoon Rhee
Eunok Im

Frontiers in Immunology

doi 10.3389/fimmu.2024.1481699

992 views

Case Report

Published on 17 Dec 2024

Biologic drugs induced vitiligo: case reports and review of literature

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Xinyi Shao
Tingqiao Chen
Xingyu Pan
Shuang Chen
Yangmei Chen
Jin Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1455050

1,457 views

Review

Published on 17 Dec 2024

CD19 CAR-T cell therapy: a new dawn for autoimmune rheumatic diseases?

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Carlos Rangel-Peláez
Laura Martínez-Gutiérrez
María Tristán-Manzano
José Luis Callejas
Norberto Ortego-Centeno
Francisco Martín
Javier Martín

Frontiers in Immunology

doi 10.3389/fimmu.2024.1502712

2,416 views

Review

Published on 17 Dec 2024

Immune dysregulation as a driver of bronchiolitis obliterans

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Kuimiao Deng
Gen Lu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1455009

705 views

Systematic Review

Published on 16 Dec 2024

Fatal outcome related to drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis of FAERS database and a systematic review of cases

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Chunsu Liang
Pengjiao An
Yizhou Zhang
Xin Liu
Bo Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1490334

1,175 views

Case Report

Published on 16 Dec 2024

Case report: paraneoplastic cerebellar degeneration associated with anti-Yo antibody successfully treated with ofatumumab

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Jingjing Dou
Xiaotong Yue
Haitao Ren
Chunjuan Wang
Shougang Guo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1476397

732 views

Original Research

Published on 16 Dec 2024

Clinical characteristics and prognostic factors of COVID-19 in rheumatic patients and their family members: a retrospective study

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Yihua Fan
Yiwen Wang
Juanli Du
Rui Wu
Jianbin Li
Changhong Xiao
Qing Li
Mi Zhou
Ying Liu
Di Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1439242

556 views

Case Report

Published on 16 Dec 2024

Case report: Detecting giant cell arteritis in [68Ga]Ga-DOTA-Siglec-9-PET/CT

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Simon M. Petzinna
Jim Küppers
Benedikt Schemmer
Anna L. Kernder
Claus-Jürgen Bauer
Leon von der Emde
Babak Salam
Jörg H. W. Distler
Anja Winklbauer
Markus Essler

Frontiers in Immunology

doi 10.3389/fimmu.2024.1501790

629 views

Original Research

Published on 16 Dec 2024

Impact of Janus kinase inhibitors and methotrexate on interstitial lung disease in rheumatoid arthritis patients

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Shota Kurushima
Tomohiro Koga
Masataka Umeda
Naoki Iwamoto
Ritsuko Miyashita
Takatomo Tokito
Daisuke Okuno
Hirokazu Yura
Hiroshi Ishimoto
Takashi Kido

Frontiers in Immunology

doi 10.3389/fimmu.2024.1501146

1,766 views

Navigation group

Articles

Evaluation of link between COVID-19 adjacent spike in hydroxychloroquine use and increased reports of pemphigus: a disproportionality analysis of the FDA Adverse Event Reporting System

Melittin as a therapeutic agent for rheumatoid arthritis: mechanistic insights, advanced delivery systems, and future perspectives

Infiltrating macrophages and interferon gamma rather than renal genotype dictate heightened crescentic glomerulonephritis

Unmasking inborn errors of immunity: identifying the red flags of immune dysregulation

CAR T-cell therapy for systemic lupus erythematosus: current status and future perspectives

Serum fatty acid profiles in systemic lupus erythematosus and patient reported outcomes: The Michigan Lupus Epidemiology & Surveillance (MILES) Program

Efficacy analysis of rituximab in treating patients with primary membranous nephropathy dependent on calcineurin inhibitors

Myeloid-specific deletion of autotaxin inhibits rheumatoid arthritis and osteoclastogenesis

Biologic drugs induced vitiligo: case reports and review of literature

CD19 CAR-T cell therapy: a new dawn for autoimmune rheumatic diseases?

Immune dysregulation as a driver of bronchiolitis obliterans

Fatal outcome related to drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis of FAERS database and a systematic review of cases

Case report: paraneoplastic cerebellar degeneration associated with anti-Yo antibody successfully treated with ofatumumab

Clinical characteristics and prognostic factors of COVID-19 in rheumatic patients and their family members: a retrospective study

Case report: Detecting giant cell arteritis in [68Ga]Ga-DOTA-Siglec-9-PET/CT

Impact of Janus kinase inhibitors and methotrexate on interstitial lung disease in rheumatoid arthritis patients